COVAXIN

dgcicovaxinforkidsinemergency - Sakshi Post
Apr 26, 2022
Hyderabad: The Drugs Controller General of India (DCGI) has granted restricted emergency use authorization to Bharat Biotech's COVID vaccine, Co
100 Crore Defamation Case: Telangana Court Directs 'The Wire' To Take Down Articles Against Bharat Biotech - Sakshi Post
Feb 24, 2022
HYDERABAD: Pharmaceutical company and COVAXIN manufacturer Bharat Biotech filed a defamation suit of Rs.
 - Sakshi Post
Jan 13, 2022
Bharat Biotech on Wednesday said that COVAXIN has a neutralizing effect on the Omicron and Delta variants of COVID-19.
 - Sakshi Post
Jan 06, 2022
COVID-19 vaccination drive for the children in the age group of 15-18 years of age started on January 1, 2022.
 - Sakshi Post
Jan 05, 2022
Confusion surrounding Covid19 vaccine Covaxin's expiry status has sparked considerable skepticism among parents, who are unconvinced by a central government statement on the subject.
 - Sakshi Post
Jan 03, 2022
India starts vaccinating 15 to 18 years olds from January 3. More than six lakh children have completed their registrations till Sunday evening on CoWIN app.
Teens in India Will Get Only Covaxin Jabs  - Sakshi Post
Dec 28, 2021
New Delhi, India: The government has said that only Covaxin will be administered to teens aged 15 to 18 years old who will be vaccinated beginning January 3 across the country.
 - Sakshi Post
Dec 27, 2021
Prime Minister Narendra Modi had announced that vaccinations for children between 15 and 18 years will start on January 3, 2022. Bharat Biotech’s covid-19 vaccine Covaxin has received approval for...
 - Sakshi Post
Dec 26, 2021
The Drug Controller General of India (DCGI) on Saturday approved Bharat Biotech's COVID-19 vaccine Covaxin for emergency use on children between the ages of 12 and 18. The vaccine is not for children...
Covaxin Gets Shelf Life Extension Of Up To 12 Months - Sakshi Post
Dec 21, 2021
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's shelf life up to 12 months from the date of manufacture, the vaccine-...
Those Who Took Covaxin Don't Have to Worry About Omicron, Here's Why  - Sakshi Post
Dec 04, 2021
According to an Indian Council of Medical Research (ICMR) officer, Bharat Biotech's COVID vaccine, "Covaxin," may be more effective against the highly-mutating Omicron variant that appeared this week.
 - Sakshi Post
Nov 01, 2021
Finally, the government of Australia has added Covaxin developed by India's Bharat Biotech to its list of approved COVID-19 vaccines. Now, the Indians who have got COVAXIN wil be allowed to enter the...
 - Sakshi Post
Oct 27, 2021
The World Health Organization's technical advisory group requested "further clarifications" from Bharat Biotech for its COVID-19 vaccine ‘Covaxin’ on Tuesday in order to complete a final risk-benefit...
 - Sakshi Post
Oct 13, 2021
The expert panel of the central drug regulator has recommended that Bharat Biotech's Covaxin be given marketing authorization with conditions for restricted emergency use (EUA)
 - Sakshi Post
Sep 28, 2021
The World Health Organisation has once again delayed the emergency use authorization of Hyderabad-based Bharat Biotech’s Covaxin.
 - Sakshi Post
Sep 15, 2021
Other Indian and international vaccines have already received approval from WHO but Bharat Biotech’s Covid-19 vaccine, Covaxin was still awaiting the answer.
 - Sakshi Post
Aug 31, 2021
Hyderabad-based vaccine maker Bharat Biotech is now working on a partnership with international drugmakers for their vaccine.
Bharat Biotech's Covaxin effective against Delta Plus variant of COVID-19: ICMR study - Sakshi Post
Aug 02, 2021
With Delta Plus variant and Third Wave looming over the country, news is that the Bharat Biotech's COVID-19 vaccine Covaxin is effective against Delta Plus (AY.1) variant of the coronavirus, as...
 - Sakshi Post
Jul 13, 2021
Hyderabad-based Bharat Biotech manufactured vaccine, Covaxin is facing issues with international recognition. Earlier it was reported that Covaxin had not received the approval from World Health...
 - Sakshi Post
Jul 01, 2021
Since the Indian vaccines, Covaxin or Covishield are facing trouble in the European countries, the Indian government has stepped up and warned of consequences if their citizens face any issues in...
 - Sakshi Post
Jun 30, 2021
Hyderabad: The city-based Bharat Biotech is now carrying out clinical trials for Covaxin to understand its safety for children.
 - Sakshi Post
Jun 30, 2021
The Bharat Biotech and Indian Council of Medical Research vaccine Covaxin effectively neutralizes the new concerning variants, Alpha and Delta, said the U.S.’ National Institute of Health.
 - Sakshi Post
Jun 25, 2021
The Covaxin Covid-19 vaccine created by Hyderabad-based Bharat Biotech is likely to be administered under emergency authorization and it may soon get full license approval, according to a senior...
 - Sakshi Post
Jun 23, 2021
New Delhi: According to Delhi AIIMS Chief Dr. Randeep Guleria, Covaxin, India's first indigenous COVID-19 vaccine will be available for children by September.
 - Sakshi Post
Jun 16, 2021
Bharat Biotech in a reply to the Central Drugs Standard Control Organisation (CDSCO) has said that, "The newborn calf serum is used in the revival process of Vero cells, which is further used for the...
 - Sakshi Post
Jun 15, 2021
Maryland based Novavax on Monday said that its vaccine had demonstrated 100 per cent protection in late-stage trials against SARS-CoV-2- a boost for the prospects of its Indian version, Covovax. The...
 - Sakshi Post
Jun 12, 2021
Covaxin is facing the dangers of being rejected by certain countries. Earlier it was not given approval by the WHO and now the vaccine didn’t receive EUA from FDA. This can mean trouble for millions...
 - Sakshi Post
Jun 11, 2021
The Indian government started the vaccination drive with Covishield and Covaxin in January this year. However, later it approved Russia's Sputnik-V vaccine for only emergency use.
 - Sakshi Post
Jun 07, 2021
Telangana’s Minister for Municipal Administration and Urban Development, Industries, and Information Technology, KT Rama Rao, took to Twitter on Sunday evening for an #AskKTR session. KTR answered...
 - Sakshi Post
Jun 05, 2021
Many US colleges and universities have informed the students to get vaccinated ahead of the Autumn semester.
 - Sakshi Post
May 22, 2021
As the Covid-19 pandemic continues to spread through India, the country can consider itself fortunate in that it has two locally produced vaccines to combat the virus, despite the fact that the...
 - Sakshi Post
May 21, 2021
Bharat Biotech announced that it is planning to increase the manufacturing capacity of Covaxin, its Covid-19 vaccine, by an additional 200 million doses per year.
 - Sakshi Post
May 17, 2021
The health ministry on Monday said that a government panel on AEFI (adverse events following immunisation) has found 26 potential cases of bleeding and clotting after administration of the Covid-19...
 - Sakshi Post
May 16, 2021
Bharat Biotech on Sunday shared that Covaxin has found to be effective against the coronavirus strains found in India and the UK.
 - Sakshi Post
May 15, 2021
While India is battling the second wave of the Covid-19 pandemic, the scarcity of vaccines has robbed people of the hope of keeping the virus at bay.
 - Sakshi Post
May 14, 2021
In a very shocking incident, a 72 year old man was administered two different COVID-19 vaccines. The incident took place in Maharashtra.
 - Sakshi Post
May 12, 2021
India battling the second wave of the coronavirus pandemic with a record surge in daily cases and deaths due to COVID-19.
 - Sakshi Post
May 10, 2021
Hyderabad: The first day of distribution of the second dose of Covid-19 vaccines in the state saw chaos at nearly all vaccination centres, with people lined up for spot registrations and vaccinations.
 - Sakshi Post
Apr 30, 2021
The Telangana government is in talks with Bharat Biotech and Dr Reddy’s Laboratories (DRL) for procuring Covid-19 vaccines in the state to ensure all those above 18 get the jab.
 - Sakshi Post
Apr 29, 2021
Serum Institute of India(SII) CEO Adar Poonawalla announced on Wednesday that Covishield's procurement price for state governments would be slashed from Rs.400 to Rs.300 per dose.
 - Sakshi Post
Apr 28, 2021
Hyderabad-based Bharat Biotech is all ready to increase the production of its indigenously developed Covaxin to 12 million doses a month by July. Currently, the company is producing only 5 million.
Covaxin demonstrates 78 percent efficacy in Phase-3 interim analysis -Bharat Biotech - Sakshi Post
Apr 21, 2021
HYDERABAD: Bharat Biotech-developed Covaxin demonstrated 78 percent efficacy  in treating COVID-19  as per reports released by the company.
Back to Top